NCT01838395 2024-09-19Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML PatientsBioLineRx, Ltd.Phase 2 Completed42 enrolled 19 charts
NCT03154827 2024-09-05Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab for Maintenance Treatment in Subjects With Acute Myeloid Leukemia (AML)BioLineRx, Ltd.Phase 1/2 Terminated1 enrolled 6 charts